查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1992541

外科黏合剂市场：2026-2032年全球市场预测（按产品、成分、手术方法、应用和最终用户划分）

Surgical Adhesives Market by Product, Composition, Surgical Method, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科黏合剂市场价值将达到 19.2 亿美元，到 2026 年将成长到 21 亿美元，到 2032 年将达到 37.4 亿美元，复合年增长率为 9.96%。

主要市场统计数据
基准年 2025 19.2亿美元
预计年份：2026年 21亿美元
预测年份：2032年 37.4亿美元
复合年增长率 (%) 9.96%

对临床需求、外科技术变革和营运限制如何重塑现代外科医学中组织黏合剂的优先事项进行策略概述。

在外科黏合剂领域，临床创新、监管完善和医疗服务管道的演变等关键因素相互交织，重新定义了现代外科手术中组织通路建立和止血的方式。过去十年，在微创手术的兴起、人们对手术效果期望的不断提高以及对手术全期资源成本效益的日益重视的推动下，黏合剂技术已从一种辅助工具发展成为外科手术工具包的核心组成部分。因此，从研发人员和契约製造到医院采购团队和临床医生，整个价值链上的相关人员正在重新评估产品系列、供应模式以及推广应用所需的实证依据。

微创手术、生物材料的突破、不断变化的监管要求以及供应链的重组，是如何全面重塑外科黏合剂市场的？

多项变革性转变正在加速整个外科黏合剂生态系统的变革，每一项都重塑了产品开发的重点和商业化路径。首先，微创手术的持续发展增加了对适用于内视镜给药、快速聚合以及减少热损伤和机械损伤的黏合剂的需求，从而凸显了可透过狭窄管腔和铰接式器械进行应用的材料科学创新。其次，随着对品质指标和基于价值的采购方式的日益重视，医疗系统要求提供强有力的临床证据，证明使用黏合剂能够带来可衡量的结果，例如降低渗漏率、缩短手术时间和降低再入院风险。

关税和贸易政策的不确定性所带来的成本压力如何推动外科黏合剂链的韧性、供应商多元化以及生产地点的重新评估？

随着製造商和医疗保健系统评估关税措施对原材料采购、定价策略和供应商选择的间接影响，贸易政策与可预测供应链之间的相互作用变得日益重要。在关税措施集中的地区，企业反映原物料和零件成本面临上涨压力，波及采购谈判和库存计画决策。为此，许多企业优先考虑供应商多元化、储备关键材料以及与物流合作伙伴密切合作，以降低关税波动带来的风险。

精准的市场区隔洞察，揭示产品类型、成分、手术方法、应用和最终用户趋势的交会点，从而形成竞争优势。

深入的细分市场分析揭示了外科黏合剂领域创新与需求的交汇点，而这种细緻的分析对于确定研发和商业化倡议的优先顺序至关重要。从产品类型来看，胶原蛋白基黏合剂、氰基丙烯酸酯基黏合剂、纤维蛋白胶、亲水胶体基黏合剂和硅酮基黏合剂各自具有不同的性能特征和临床应用场景。有些技术适用于快速止血，而有些技术则提供持续的组织渗透性和良好的皮肤相容性。这种产品层面的差异与生物来源黏合剂和合成黏合剂之间的成分差异密切相关。生物来源配方通常优先考虑生物相容性和吸收性，而合成替代品则倾向于调节机械性能和储存稳定性。

美洲、欧洲、中东和非洲以及亚太地区等不同区域的实施模式和监管趋势存在差异，这影响着市场进入和业务扩大策略。

细微的区域差异导致需求模式、技术采纳率和监管合规策略各不相同，企业在规划市场进入和扩张时必须仔细考虑这些因素。在美洲，完善的医院网路和许多先进的外科中心为实证黏合剂和新型给药系统的快速推广创造了有利环境，但采购流程高度分散且对价格敏感。在欧洲、中东和非洲，管理体制和临床实践各不相同。欧洲主要医疗保健系统通常要求提供严格的临床数据和正式的医疗技术评估，而该地区的其他市场可能更注重产品的可近性和可负担性，从而导致不同的商业性策略。

为什么临床疗效证明、生产规模、策略伙伴关係和上市后证据生成是外科黏合剂竞争的决定性因素？

在外科黏合剂领域，竞争地位越来越取决于科学差异化、生产能力以及展现显着临床效益的能力。那些强调经临床检验的产品特性（例如在潮湿环境下快速密封、降低发炎反应或与微创给药方式相容）的公司，往往能获得三级医疗机构早期用户的更强劲支持。同时，在生产和分销方面实现规模经济仍然至关重要，这有助于在价格敏感的分销管道中保持竞争力，并支持全球范围内的监管申报。

领导者应实施的策略重点是加强创新管道、巩固供应链、加速临床应用以及使商业模式适应以金额为准融资。

寻求可持续价值的产业领导者应采取多管齐下的策略，将产品创新、业务永续营运和强有力的临床证据相结合。首先，他们应优先投资研发能够满足尚未满足的临床需求的配方（特别是专为微创给药和传统封闭方式难以应用的解剖部位设计的黏合剂），同时考虑采用模组化产品组合策略，平衡生物和合成平台。其次，他们应透过关键原材料的双重采购、生产能力的选择性地域分配以及确保在贸易和物流中断期间柔软性的合约条款，来增强供应链的韧性。

为了支持我们的结论和建议，我们采用了严格的混合方法研究框架，结合了对临床医生的访谈、采购见解、监管审查和三角验证的二手证据。

本分析整合了主要调查和次要调查的调查方法，以确保对实证建议和研究结果进行严格检验。主要调查包括对专科临床医生、医院系统和门诊手术中心的采购经理、製造专家以及监管事务专家进行的结构化访谈。这些访谈提供了对采纳驱动因素、流程和采购挑战的定性理解，并透过专家咨询会议检验了解释的有效性，随后对策略影响进行了压力测试。

简要概述决定哪些外科黏合剂技术能够实现持续临床应用和商业性成功的策略挑战。

总而言之，外科黏合剂产业正处于一个转折点，需要将材料创新、手术流程改进和商业策略紧密结合，才能创造临床和经济价值。能够满足微创手术技术要求、在各种临床环境中提供可重复性能，并拥有可靠的真实世界数据支援的黏合剂技术，对于优先考虑疗效和效率的医疗系统而言，最具吸引力。同时，能够透过供应链的灵活性和精心製定的区域打入市场策略，确保供应连续性并满足区域监管要求的公司，将能够在竞争中脱颖而出。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科黏合剂市场：依产品划分

  • 胶原蛋白黏合剂
  • 氰基丙烯酸黏合剂
  • 纤维蛋白胶
  • 亲水胶体黏合剂
  • 硅基黏合剂

第九章 外科黏合剂市场：依成分划分

  • 生物基黏合剂
  • 合成黏合剂

第十章 外科黏合剂市场：依手术方法划分

  • 微创手术
  • 开放性手术

第十一章黏合剂市场：按应用领域划分

  • 心血管外科
  • 整形手术
  • 一般外科
  • 整形外科手术

第十二章 外科黏合剂市场：依最终用户划分

  • 门诊手术中心
  • 医院和诊所
  • 专业医疗中心

第十三章 外科黏合剂市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章黏合剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 外科黏合剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国外科黏合剂市场

第十七章：中国外科黏合剂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Advanced Medical Solutions Group PLC
  • Artivion, Inc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Cardinal Health, Inc.
  • Chemence Medical, Inc.
  • Connexicon Medical Limited
  • CSL Behring AG
  • GEM Srl
  • GluStitch Inc.
  • Grena Ltd.
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kuraray America, Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Meyer-Haake GmbH Medical Innovations
  • Mitsui Chemicals, Inc.
  • Nordson Corporation
  • Sealantis Ltd.
  • UFP Technologies Inc.
  • Vivostat A/S
Product Code: MRR-5456033C8C0A

The Surgical Adhesives Market was valued at USD 1.92 billion in 2025 and is projected to grow to USD 2.10 billion in 2026, with a CAGR of 9.96%, reaching USD 3.74 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.92 billion
Estimated Year [2026] USD 2.10 billion
Forecast Year [2032] USD 3.74 billion
CAGR (%) 9.96%

A strategic overview of how clinical demands, procedural shifts, and operational constraints are reshaping priorities for tissue adhesives across contemporary surgical practice

The surgical adhesives landscape is experiencing a pivotal convergence of clinical innovation, regulatory refinement, and shifting care delivery pathways that together are redefining how tissue approximation and hemostasis are achieved in modern surgery. Over the past decade, adhesive technologies have evolved from niche adjuncts to core components of procedural toolkits, driven by the push toward less invasive interventions, heightened expectations for surgical outcomes, and a growing emphasis on cost-effective perioperative resource utilization. Consequently, stakeholders across the value chain-from developers and contract manufacturers to hospital procurement teams and clinicians-are reassessing product portfolios, supply models, and the evidence base required for adoption.

This report begins by framing the clinical imperatives that are influencing adhesive selection, including surgeon preference patterns, patient safety priorities, and the increasing demand for adhesives that deliver reliable sealing with minimal tissue reaction. It then situates those imperatives within operational realities such as sterilization standards, packaging innovation, and inventory management pressures in high-throughput settings. By connecting clinical need to commercial strategy, the introduction clarifies why adhesives that balance performance, ease of use, and regulatory compliance are positioned to win in environments where productivity and outcomes are both scrutinized. As a result, leaders must integrate clinical validation, manufacturing resilience, and payer considerations into their product development and go-to-market roadmaps.

How minimally invasive procedures, biomaterials breakthroughs, evolving regulatory expectations, and supply chain reconfiguration are collectively redefining the surgical adhesives landscape

Several transformative shifts are accelerating change across the surgical adhesives ecosystem, each reshaping product development priorities and commercial pathways. First, the persistent migration toward minimally invasive surgery is amplifying demand for adhesives optimized for endoscopic delivery, rapid polymerization, and reduced thermal or mechanical trauma, thereby privileging materials science innovations that can be deployed through narrow lumens and articulated instruments. Second, an expanding emphasis on quality metrics and value-based procurement is compelling health systems to demand robust clinical evidence that links adhesive use to measurable outcomes such as reduced leak rates, shorter procedure times, or lower readmission risks.

Concurrently, advances in biomaterials are creating new classes of adhesives that combine bioresorbability with targeted adhesion profiles, enabling tissue-specific solutions for cardiovascular, orthopedic, and dermal applications. Regulatory pathways have also matured, with authorities signaling clearer expectations for clinical data and manufacturing controls, which affects time-to-market and commercialization strategy. Finally, global supply chain complexities and evolving procurement practices are prompting companies to pursue strategic partnerships, local manufacturing capabilities, and integrated service offerings that help customers manage cost and continuity of supply. Taken together, these shifts emphasize the need for cross-functional alignment between R&D, regulatory, and commercial teams to convert scientific progress into sustained market access and clinical adoption.

How tariff-induced cost pressures and trade policy uncertainty are driving supply chain resilience, supplier diversification, and production footprint reassessment across surgical adhesive supply chains

The interplay between trade policy and predictable supply chains has taken on renewed importance as manufacturers and health systems evaluate the indirect effects of tariff actions on input sourcing, pricing strategy, and supplier selection. In jurisdictions where tariff measures have been concentrated, companies have reported upward pressure on raw material and component costs, which has cascaded into procurement negotiations and inventory planning decisions. In response, many organizations have prioritized supplier diversification, stockpiling of critical inputs, and closer collaboration with logistics partners to mitigate exposure to tariff-induced volatility.

Beyond immediate cost implications, tariff dynamics influence strategic choices about production footprint and nearshoring. Firms seeking tariff resilience are weighing the trade-offs of localized manufacturing capacity versus the capital intensity of facility establishment. At the same time, procurement teams are re-evaluating long-term contracts to introduce greater flexibility for renegotiation or indexation to input cost movements. Clinically, the potential for supply interruptions has prompted stronger emphasis on qualifying multiple adhesive formulations and packaging options to ensure continuity of care. Taken together, these adjustments do not merely reflect short-term cost management; they signal a structural reorientation toward greater supply chain agility, contractual sophistication, and scenario planning that together reduce operational risk and preserve access to critical surgical consumables.

Precise segmentation insights that reveal where product type, composition, surgical method, application, and end-user dynamics converge to shape competitive advantage

Insightful segmentation analysis illuminates where innovation and demand intersect within the surgical adhesives arena, and this granularity is essential for prioritizing R&D and commercial initiatives. Across product types, collagen-based adhesives, cyanoacrylate adhesives, fibrin sealants, hydrocolloid adhesives, and silicone adhesives each present distinct performance profiles and clinical use cases, with some technologies better suited to rapid hemostasis while others provide durable tissue approximation or dermal compatibility. This product-level differentiation interacts closely with composition-based distinctions between biological adhesives and synthetic adhesives; biological formulations commonly emphasize biocompatibility and resorbability whereas synthetic alternatives frequently focus on tunable mechanical properties and shelf stability.

The surgical method segmentation-minimally invasive surgery versus open surgery-further shapes design priorities, as instruments and delivery modalities for less invasive approaches demand adhesives with lower viscosity, controlled curing kinetics, and compatibility with endoscopic applicators. Application areas such as cardiovascular surgery, cosmetic surgery, general surgery, and orthopedic surgery impose unique performance constraints and evidence requirements; for instance, cardiovascular use cases place heightened emphasis on hemostatic reliability and thromboresistance while cosmetic procedures prioritize aesthetic outcomes and scar minimization. End-user contexts, including ambulatory surgical centers, hospitals & clinics, and specialty care centers, influence procurement cycles, packaging preferences, and the level of training expected for clinical staff. By synthesizing these segmentation lenses, decision-makers can identify which adhesive technologies warrant prioritized investment based on clinical fit, adoption barriers, and the operational models of target customers.

Regionally differentiated adoption patterns and regulatory dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape tailored market entry and scale strategies

Regional nuances drive differentiated demand patterns, technology adoption rates, and regulatory engagement strategies that companies must navigate when planning market entry and expansion. In the Americas, robust hospital networks and a concentration of advanced surgical centers create a favorable environment for high-evidence adhesives and rapid uptake of novel delivery systems, but procurement processes can be highly decentralized and price-sensitive. Europe, the Middle East & Africa present heterogeneous regulatory regimes and clinical practices; while major European health systems often require rigorous clinical data and formal health technology assessments, other markets in the region may prioritize availability and affordability, creating distinct commercial pathways.

Asia-Pacific markets exhibit dynamic contrasts between advanced tertiary centers that rapidly adopt cutting-edge adhesives and vast community settings where cost and distribution efficiency are paramount. Furthermore, regional manufacturing capabilities and regulatory frameworks influence decisions about local production versus export models, and partnerships with regional distributors remain critical to navigating complex reimbursement and procurement landscapes. Understanding these regional differences enables companies to tailor evidence generation, pricing strategies, and go-to-market models to local expectations while preserving a coherent global product narrative that supports scale and regulatory convergence where possible.

Why clinical validation, manufacturing scale, strategic partnerships, and post-market evidence generation are decisive factors for competitive strength in surgical adhesives

Competitive positioning in the surgical adhesives sector is increasingly defined by the combination of scientific differentiation, manufacturing capability, and the ability to demonstrate meaningful clinical benefit. Organizations that emphasize clinically validated product attributes-such as rapid sealing under wet conditions, reduced inflammatory response, or compatibility with minimally invasive delivery-tend to achieve stronger traction with early adopters in tertiary centers. At the same time, scale advantages in manufacturing and distribution remain important for competing in price-sensitive channels and for supporting global regulatory submissions.

Strategic behaviors observed among leading players include targeted partnerships with clinical research centers to build the evidence base, investments in sterile fill-finish and packaging innovation to improve shelf life and usability, and selective M&A to acquire complementary technologies or expand presence in key therapeutic applications. Companies that combine a disciplined pipeline of differentiated formulations with robust quality systems and demonstrated supply continuity are better positioned to win long-term contracts with large health systems. Finally, firms that invest in clinician education and post-market surveillance generate the real-world data necessary to support product claims and inform iterative improvements, thereby reinforcing both clinical credibility and commercial defensibility.

Actionable strategic priorities for leaders to strengthen innovation pipelines, fortify supply chains, accelerate clinical adoption, and align commercial models with value-based procurement

Industry leaders seeking to capture sustainable value should adopt a multifaceted strategy that aligns product innovation with operational resilience and compelling clinical evidence. First, prioritize R&D investments in formulations that address unmet clinical needs-particularly adhesives engineered for minimally invasive delivery and for anatomies where conventional closure is challenging-while also considering modular portfolio strategies that balance biological and synthetic platforms. Second, enhance supply chain resilience through dual-sourcing of critical inputs, selective regional manufacturing capacity, and contractual clauses that provide flexibility in the event of trade or logistics disruption.

Third, accelerate clinical adoption by investing in high-quality, procedure-specific evidence and by designing training programs that reduce learning curves for surgeons and perioperative staff. Fourth, engage proactively with regulators and payers to shape pathways that recognize outcome-based benefits and to streamline reimbursement discussions. Fifth, adopt pricing and contracting models that reflect total cost of care benefits rather than unit price alone, which can unlock procurement dialogues in value-oriented health systems. Finally, pursue partnerships with device manufacturers, surgical platforms, and distribution networks to expand reach while preserving focus on core technological strengths. These steps collectively enable market leaders to translate scientific advantage into durable commercial outcomes.

A rigorous mixed-methods research framework combining clinician interviews, procurement insights, regulatory review, and triangulated secondary evidence to underpin conclusions and recommendations

This analysis integrates primary and secondary research methods to ensure evidence-based recommendations and rigorous validation of insights. Primary research comprised structured interviews with clinicians across specialties, procurement leaders in hospital systems and ambulatory surgical centers, manufacturing experts, and regulatory affairs professionals. These interviews informed qualitative understanding of adoption drivers, procedural workflows, and procurement sensitivities, and were supplemented by expert advisory sessions to validate interpretation and to stress-test strategic implications.

Secondary research drew on peer-reviewed clinical literature, regulatory guidance documents, product labeling and instructions for use, patent filings, and company disclosures to establish technical context and to confirm material science developments. Data synthesis applied triangulation techniques to reconcile differing inputs and to identify consistent themes across geographies and stakeholder groups. Throughout, emphasis was placed on transparency of assumptions, reproducibility of analytical approaches, and the separation of descriptive findings from strategic interpretation, enabling readers to trace the evidentiary basis for each recommendation and to adapt insights to their organizational context.

A concise synthesis of the strategic imperatives that will determine which surgical adhesive technologies achieve durable clinical adoption and commercial success

In summary, the surgical adhesives sector stands at an inflection point where materials innovation, procedural evolution, and commercial strategy must be tightly aligned to realize clinical and economic value. Adhesive technologies that respond to the technical demands of minimally invasive surgery, that offer reproducible performance in varied clinical settings, and that are supported by robust real-world evidence will be the most compelling to health systems focused on outcomes and efficiency. Concurrently, supply chain agility and thoughtful regional go-to-market approaches will differentiate companies able to ensure continuity of supply and to meet localized regulatory expectations.

As stakeholders navigate these dynamics, success will favor organizations that integrate scientific differentiation with disciplined operations, proactive regulatory engagement, and targeted clinical programs. By focusing on these priorities, industry participants can convert emerging opportunities into sustainable adoption and long-term partnership with the clinical community.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Adhesives Market, by Product

  • 8.1. Collagen-Based Adhesives
  • 8.2. Cyanoacrylate Adhesives
  • 8.3. Fibrin Sealants
  • 8.4. Hydrocolloid Adhesives
  • 8.5. Silicone Adhesives

9. Surgical Adhesives Market, by Composition

  • 9.1. Biological Adhesives
  • 9.2. Synthetic Adhesives

10. Surgical Adhesives Market, by Surgical Method

  • 10.1. Minimally Invasive Surgery
  • 10.2. Open Surgery

11. Surgical Adhesives Market, by Application

  • 11.1. Cardiovascular Surgery
  • 11.2. Cosmetic Surgery
  • 11.3. General Surgery
  • 11.4. Orthopedic Surgery

12. Surgical Adhesives Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics
  • 12.3. Specialty Care Centers

13. Surgical Adhesives Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Adhesives Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Adhesives Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Surgical Adhesives Market

17. China Surgical Adhesives Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Advanced Medical Solutions Group PLC
  • 18.7. Artivion, Inc
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. Becton, Dickinson, and Company
  • 18.11. Cardinal Health, Inc.
  • 18.12. Chemence Medical, Inc.
  • 18.13. Connexicon Medical Limited
  • 18.14. CSL Behring AG
  • 18.15. GEM S.r.l.
  • 18.16. GluStitch Inc.
  • 18.17. Grena Ltd.
  • 18.18. H.B. Fuller Company
  • 18.19. Henkel AG & Co. KGaA
  • 18.20. Integra LifeSciences Holdings Corporation
  • 18.21. Johnson & Johnson Services, Inc.
  • 18.22. Kuraray America, Inc.
  • 18.23. Medline Industries, LP
  • 18.24. Medtronic PLC
  • 18.25. Meyer-Haake GmbH Medical Innovations
  • 18.26. Mitsui Chemicals, Inc.
  • 18.27. Nordson Corporation
  • 18.28. Sealantis Ltd.
  • 18.29. UFP Technologies Inc.
  • 18.30. Vivostat A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COLLAGEN-BASED ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HYDROCOLLOID ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SILICONE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COSMETIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY SPECIALTY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. GCC SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. GCC SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GCC SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 129. G7 SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. G7 SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. G7 SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. G7 SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 135. NATO SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. NATO SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. NATO SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA SURGICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA SURGICAL ADHESIVES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA SURGICAL ADHESIVES MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA SURGICAL ADHESIVES MARKET SIZE, BY SURGICAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA SURGICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA SURGICAL ADHESIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)